Clinical Trial Update: A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a human anti-ICAM-1 monoclonal antibody in multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Human anti-ICAM-1 monoclonal antibody (anti-ICAM-1 monoclonal antibody)

Snippet

Sponsor: BioInvent International AB | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED